LUXTURNA has significant market potential due to the high unmet need for effective treatments in rare genetic conditions. With its FDA approval for specific mutations in the RPE65 gene, it offers ...
13h
DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...
The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, ...
20h
Databricks, the Data and AI company, and Anthropic, an AI safety and research company, today announced a strategic, five-year partnership ...
In a recent report, JLL said industrial rent growth in Sydney was mixed in Q4 2024, with the inner precincts remaining flat ...
The Kuala Lumpur City Centre prime retail market outlook remains optimistic, according to a JLL report. Prime malls are ...
The famous Twitter' bird l o go' sign that once adorned the company's Market Square headquarters in San Francisco has sold ...
EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules 24.03.2025 / 13:05 CET/CEST The issuer is ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback